http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2022160022-A1
Outgoing Links
| Predicate | Object |
|---|---|
| assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_44c4b3f6c2fbf6754168da326e7d3652 |
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-4439 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-50 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K38-26 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-4985 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-155 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P3-10 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-4985 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-4439 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-56 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P3-10 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K38-26 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-155 |
| filingDate | 2021-02-08-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_144d640fba5619b5b9cbdfcec6e0d954 |
| publicationDate | 2022-08-04-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | WO-2022160022-A1 |
| titleOfInvention | Long-lasting resorbable subcutaneous implant with prolonged release of pre-concentrated pharmacologically active substance in polymer for the treatment of type 2 diabetes mellitus and method |
| abstract | The present invention patent pertains to the healthcare sector and comprises a long-lasting resorbable subcutaneous implant with prolonged release of a pre-concentrated pharmacologically active substance in a polymer for the treatment of type 2 diabetes mellitus. The biodegradable implant is inserted subcutaneously and provides continuous release of the active substance for an extended period of time. The implant is preferably made up of particles of the active substance uniformly dispersed in a bioerodible and bioabsorbable polymer matrix. The implants can be of any size, shape and structure that enable manufacture and subcutaneous insertion. However, the implants must have geometric shapes that retain their surface area over time to ensure a more constant and uniform release of the active substance. |
| priorityDate | 2021-01-29-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 207.